American regulators were due to meet Thursday to assess the Pfizer coronavirus vaccine for emergency approval, as the country logged one of its worst-ever daily Covid-19 death tolls with more than 3,000 people lost to the pandemic.

Other northern hemisphere countries were also grappling with a winter virus surge, as the number of global infections raced towards 70 million with more than 1.5 million deaths.

It is not confirmed when the US Food and Drug Administration will issue the emergency authorization for the Pfizer-BioNTech vaccine, but Health Secretary Alex Azar indicated that officials have early next week in mind.

“Now we actually get to do something that hopefully will bring this… pandemic to an end,” said Terri White, a nursing education specialist at UW Health in the state of Wisconsin, where staff are being trained to administer the vaccine.

“I know our whole team is really excited about that prospect… to help our lives return to normal.”

Top US government scientists said, however, that people with a known history of severe allergic reactions would be asked not to take the Pfizer vaccine, following a similar warning in Britain.

The United States is the worst-hit nation in the world, with more than 15 million known infections and close to 290,000 deaths.

US Army General Gus Perna, who is overseeing logistics nationwide, said he had given the order Wednesday to begin distributing syringes, needles, alcohol wipes and dilutants required for the Pfizer vaccine, a process expected to be completed by Friday.

The next vaccines to receive approval might be those made by Moderna, Johnson & Johnson, and AstraZeneca, most likely in that order.

The US hopes to vaccinate 20 million people this month, with long term care facility residents and health care workers at the front of the line. The goal is to reach 100 million by the end of February and the whole population by June.

SHARE

LEAVE A REPLY